Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Speakers Announced for The Battery Show Europe 2026

April 2, 2026

Calgary Police Service prepares for ‘significant’ 4-year budget request 

April 2, 2026

Aurora Mobile Unveils 500% Efficiency Boost Case Study at Tourism × Web3 Summit 2026

April 2, 2026

Low-Grade Glioma Market Trends and Investment Opportunities Through 2030 & 2035: Regional Insights for Trametinib, Dabrafenib, Ivosidenib, and Mirdametinib

April 2, 2026

MAX Power Advances Basin-Scale Discovery Potential with Multi-Zone Natural Hydrogen and Helium Intervals at Bracken

April 2, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lincoln National
Press Release

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lincoln National

By News RoomApril 26, 20243 Mins Read
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lincoln National
Share
Facebook Twitter LinkedIn Pinterest Email

NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lincoln National Corporation (“Lincoln National” or the “Company”) (NYSE: LNC) and reminds investors of the June 24, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Lincoln National To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 investing in Lincoln National stock or options between November 4, 2020 and November 2, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/LNC.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Company was experiencing a decline in its VUL business; (2) that, as a result, the goodwill associated with the life insurance business was overstated; (3) that, as a result, the Company’s policy lapse assumptions were outdated; (4) that, as a result, the Company’s reserves were overstated; (5) that, as a result, the Company’s reported financial results and financial statements were misstated; and (6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On November 2, 2022, after the market closed, Lincoln National released its third quarter 2022 financial results, reporting a net loss of $2.6 billion for the quarter. This was compared to a net income of $318 million for the third quarter of 2021 the previous year. The Company explained “[t]he current quarter’s adjusted operating results included net unfavorable notable items of $2.0 billion, or $11.62 per share, related to the company’s annual review of DAC and reserve assumptions.” The Company also disclosed that it “incurred a $634 million goodwill impairment to the life insurance business.”

On this news, Lincoln National’s stock price fell $17.27, or 33.2%, to close at $34.83 per share on November 3, 2022, on unusually heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Lincoln National’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f50d5773-df74-4301-9316-01c8dea1c1bf

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Speakers Announced for The Battery Show Europe 2026

Aurora Mobile Unveils 500% Efficiency Boost Case Study at Tourism × Web3 Summit 2026

Low-Grade Glioma Market Trends and Investment Opportunities Through 2030 & 2035: Regional Insights for Trametinib, Dabrafenib, Ivosidenib, and Mirdametinib

MAX Power Advances Basin-Scale Discovery Potential with Multi-Zone Natural Hydrogen and Helium Intervals at Bracken

Medulloblastoma Drugs Market Analysis and Growth Forecast 2026-2030 & 2035 by Drug Candidate, Product, Route of Administration, Distribution Channel, End-user and Region

MEXC Launches Mezo (MEZO) Airdrop+ Event with $50,000 in MEZO and 15,000 USDT in Rewards

MEXC Launches VVIP System Powered by M-Score, Redefining Elite Access Beyond Asset Thresholds

Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 – United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate

MEXC Spot Market Adds Ondo Tokenized Plug Power, iShares MSCI South Korea and Japan ETFs

Editors Picks

Calgary Police Service prepares for ‘significant’ 4-year budget request 

April 2, 2026

Aurora Mobile Unveils 500% Efficiency Boost Case Study at Tourism × Web3 Summit 2026

April 2, 2026

Low-Grade Glioma Market Trends and Investment Opportunities Through 2030 & 2035: Regional Insights for Trametinib, Dabrafenib, Ivosidenib, and Mirdametinib

April 2, 2026

MAX Power Advances Basin-Scale Discovery Potential with Multi-Zone Natural Hydrogen and Helium Intervals at Bracken

April 2, 2026

Latest News

Medulloblastoma Drugs Market Analysis and Growth Forecast 2026-2030 & 2035 by Drug Candidate, Product, Route of Administration, Distribution Channel, End-user and Region

April 2, 2026

MEXC Launches Mezo (MEZO) Airdrop+ Event with $50,000 in MEZO and 15,000 USDT in Rewards

April 2, 2026

MEXC Launches VVIP System Powered by M-Score, Redefining Elite Access Beyond Asset Thresholds

April 2, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version